| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2010 | US7795313 treating sarcoma, leukemia or lymphoma comprising administering disodium 2-(N'-methyl-N'-thiocyclopropyl-hydrazinocarbonyl)-1-(methyl-thiocyclopropyl-hydrazono)-ethanolate, and optionally in combination with taxol, an analog of taxol or a microtubule stabilizer agent; water solubility and bioavailability |
| 09/14/2010 | US7795312 FDA Orange book listed patent for lubiprostone; treating irritable bowel syndrome with a 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1, or a salt, ether, ester or amide thereof |
| 09/14/2010 | US7795311 protecting soybean plant or reducing mortality of a soybean seed from soil-borne fungal disease by applying carbenoxolone disodium salt and a polymer to at least a portion of soybean plant as a foliar spray to reduce the occurrence of Phytophthora spp. or Pythium spp. |
| 09/14/2010 | US7795310 Methods and reagents for the treatment of metabolic disorders |
| 09/14/2010 | US7795309 Topical formulation including diclofenac, or a pharmaceutically acceptable salt thereof |
| 09/14/2010 | US7795307 acetylcholinesterase inhibitors, comprising prodrugs of an amphetamine and a methamphetamine compounds, used for treating Alzheimer's disease |
| 09/14/2010 | US7795306 administering nuclear factor kappa B (NF- kappa B) inhibitors comprising myriceric acid A, for the treatment of inflammatory bowel disease in a mammals |
| 09/14/2010 | US7795305 CDDO-compounds and combination therapies thereof |
| 09/14/2010 | US7795304 such as S)-[6-Hydroxycarbamoyl-1-(4-phenyl-thiazol-2-ylcarbamoyl)-hexyl]-carbamic acid benzyl ester, useful in the prevention and/or treatment cancer, restenosis, autoimmune diseases, allergies, inflammatory diseases, nervous system disorders such as neurodegenerative diseases |
| 09/14/2010 | US7795302 use of topical formulation for treating rosacea containing a combination of an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 09/14/2010 | US7795301 preventing myxoviruses infection using 3-(acetylamino)-2-{3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-1-[1,2-dihydroxyethyl]-19,20-dihydroxy-3,16-dioxo-2,17-dioxa-4,15-diazaicos-1-yl}-4-{[amino(imino)methyl]-amino}-3,4-dihydro-2H--pyran-6-carboxylic acid; viricides |
| 09/14/2010 | US7795300 External preparation for skin |
| 09/14/2010 | US7795299 11,15-dioxa-cyclopenta[a]phenanthren-12-one derivatives, used for the treatment of cancer; anticarcinogenic agents |
| 09/14/2010 | US7795298 IAP BIR domain binding compounds |
| 09/14/2010 | US7795297 pharmaceutically acceptable addition salts of such compounds, pharmaceutical compositions containing such compounds, the process for their preparation, and their use as pharmacologically active substances, especially in the treatment of hypertriglyceridemia, hyperlipidemia, hypercholesterolemia, diabetes |
| 09/14/2010 | US7795296 Artificial sweenening for food, beverages |
| 09/14/2010 | US7795295 MAGIs (membrane associated guanylate kinase proteins with inverse orientation); oncosuppressive (tumor suppressor) protein; (2-(1-Hydroxypentyl)-3-(2-phenylethyl)-6-methyl)indole-5-carboxylic acid |
| 09/14/2010 | US7795293 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 09/14/2010 | US7795292 preferential adrenergic receptors agonists such as 4-(3-chloro-2-fluoro-benzyl)-1,3-dihydro-imidazole-2-thione, used as analgesics |
| 09/14/2010 | US7795291 Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-, used for treating atherosclerosis, dyslipidemia, diabetes, non-insulin dependent diabetes, hyperglycemia, hyperinsulinemia and obesity |
| 09/14/2010 | US7795290 enzyme synthetase, ligase and/or kinase inhibitors such as N-(3-(diethylamino)propyl)-N-(4-(2,5-dimethoxyphenyl)thiazol-2-yl)benzamide, used for treating Alzheimer's disease, strokes, diabetes, obesity, inflammation, cancer and rheumatoid arthritis |
| 09/14/2010 | US7795289 Use of acylaminothiazole derivatives as therapeutic agents |
| 09/14/2010 | US7795288 Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors |
| 09/14/2010 | US7795287 Therapeutic substituted hydantoins and related compounds |
| 09/14/2010 | US7795286 Silane esters and amides of 2-oxothiazolidine-4-carboxylic acid, and cosmetic uses thereof |
| 09/14/2010 | US7795284 cdc25 tyrosine phosphatase inhibitors such as 5-{[2-(dimethylamino)ethyl]amino}-2-(morpholin-4-ylcarbonyl)-1,3-benzothiazole-4,7-dione, used as anticarcinogenic agents |
| 09/14/2010 | US7795283 Oxadiazole derivative as DGAT inhibitors |
| 09/14/2010 | US7795282 Mitotic kinesin inhibitors and methods of use thereof |
| 09/14/2010 | US7795281 (R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester; calcium antagonistic action, antihypertensive action, vascular dilatory action, cardiac protective action, anti-arteriosclerotic action, diuretic action |
| 09/14/2010 | US7795280 3-(2-Nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indole-6-carbonitrile, used for the treatment of benign prostate hyperplasia, bone disorders, female sexual dysfunction,, atherosclerosis, anemia, muscular atrophy, as contraceptives or for hormone replacement therapy |
| 09/14/2010 | US7795279 reducing or inhibiting kinase activity of FLT3 in a cell or subject, and preventing or treating a cell proliferative disorder related to FLT3 using, for example, 5-Cyano-furan-2-carboxylic acid [4-(4- methyl-piperazin-1-yl)-2-(3-methyl- thiophen-2-yl)-phenyl]-amide |
| 09/14/2010 | US7795278 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 09/14/2010 | US7795277 7-(2-(4-(3-trifuloromethyl-phenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isoquinoline besylate salt, preparation and therapeutic use thereof |
| 09/14/2010 | US7795276 Imiadazo[4,5-c] pyridine compound and method of antiviral treatment |
| 09/14/2010 | US7795275 of neuropathic pain comprising administering angiotensin II receptor 2 (AT2 receptor) antagonists such as 2-(Diphenylacetyl)-5-benzyloxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
| 09/14/2010 | US7795274 6-(Carbocyclylmethyl- or heterocyclylmethyl-substituted)pyrrolo[2,3-c]pyridine derivatives; use alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or mediated conditions or diseases |
| 09/14/2010 | US7795273 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors |
| 09/14/2010 | US7795272 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| 09/14/2010 | US7795271 Substituted pyrimidinones |
| 09/14/2010 | US7795270 3-benzoyl-1-[(Z)-4-(trityloxy)-2-butenyl]-1,2,3,4-tetrahydro-2,4-pyrimidinedione; antiprotozoa agents; Deoxyuridine triphosphate nucleotidohydrolase inhibitors; malaria |
| 09/14/2010 | US7795269 3-Ethyl-1-propyl-8-{1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl}-1,3,7-trihydropurine-2,6-dione; antiasthmatic and antidiarrhea agents |
| 09/14/2010 | US7795268 Method of treating hepatic disease using A2B adenosine receptor antagonists |
| 09/14/2010 | US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia |
| 09/14/2010 | US7795266 Tetrahydroindolone derivatives for treament of neurological conditions |
| 09/14/2010 | US7795265 such as 3-(4-{[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl}-1-piperazinyl)-1-naphthoic acid, used for the treatment of obesity or diabetes |
| 09/14/2010 | US7795264 Tyrosine kinase with immunoglobulin and epidermal growth factor homology domain signaling inhibitors; dysregulated vascular growth disorders |
| 09/14/2010 | US7795263 Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals |
| 09/14/2010 | US7795262 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 09/14/2010 | US7795261 substance P receptor blockers, such as [2R-trans]-{2-benzyl-4-[4-(1-pyrazin-2-yl-pyrrolidin-3-yl)-piperazin-1-yl]-piperidin-1-yl}-(3,5-bis-trifluoromethyl-phenyl)-methanone, used for treating schizophrenia, emesis, anxiety and depression, irritable bowel syndrome, sleep disorders, pain and inflammation |
| 09/14/2010 | US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents |
| 09/14/2010 | US7795259 pyrrolo[2,3-b]pyrazine derivatives used as enzyme inhibitors for the treatment of cardiovascular disorders, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, bone disorders, cancer and viral diseases |
| 09/14/2010 | US7795258 Pyridazine compound and use thereof |
| 09/14/2010 | US7795257 Organic compounds |
| 09/14/2010 | US7795256 p38 mitogen-activated protein (MAP) kinase inhibitors such as Ethyl 3-(3-methylbenzoyl)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate, used in the treatment and/or prevention of autoimmune diseases or inflammatory disorders; antiinflammatory agents |
| 09/14/2010 | US7795255 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 09/14/2010 | US7795254 Benzomorpholine derivatives and methods of use |
| 09/14/2010 | US7795253 Condensed imidazole derivatives as aromatase inhibitors |
| 09/14/2010 | US7795252 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
| 09/14/2010 | US7795251 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders |
| 09/14/2010 | US7795250 Indole derivatives as antiviral agents |
| 09/14/2010 | US7795249 Certain pyrazoline derivatives with kinase inhibitory activity |
| 09/14/2010 | US7795248 tyrosine kinase inhibitors such as N-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-N'-phenylurea, used for treating benign or neoplastic proliferative diseases and autoimmune diseases; antitumor agents |
| 09/14/2010 | US7795247 13-Cyclohexyl-5-(2-pyrrolidin-1-ylethoxy)-6,7-dihydro-5H-indolo[2.1-a][2]benzazepine-10-carboxylic acid, for example; use for the treatment or prevention of infection by hepatitis C virus |
| 09/14/2010 | US7795246 mixture with surfactants; improvd bioavailability, stability; oral administering |
| 09/14/2010 | US7795245 Heterobicyclic metalloprotease inhibitors |
| 09/14/2010 | US7795244 of sulopenem, comprising 2-ethoxy-2-methyl-1-oxopropoxy)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, used to treat and prevent bacterial infection in humans; antibiotics |
| 09/14/2010 | US7795243 Penem prodrugs |
| 09/14/2010 | US7795242 The antigens are associated with recognition of CD1 molecules by T cells. These antigens can be used as antigens, adjuvants or as immunomodulatory agents in a variety of therapeutic and prophylactic applications |
| 09/14/2010 | US7795241 comprising 17-ethinylestradiol acetoxyacetate, used for hormone replacemnet therapy or as contraceptives; improved bioavailability |
| 09/14/2010 | US7795240 Nonreducing beta-glucan derivative |
| 09/14/2010 | US7795239 relieving symptoms of erosive and non erosive gastrointestional mucosal irritation in mammals; treats nausea and/or vomiting and/or diarrhea and/or erosions of mucosa or epithelium |
| 09/14/2010 | US7795238 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B |
| 09/14/2010 | US7795237 Pharmaceutical composition and process |
| 09/14/2010 | US7795236 8-(4'-Methylbiphenyl-4-ylmethylamino)adenosine; useful for the prevention or treatment of gout, hyperuricemia, urinary lithiasis, hyperuricemic nephropathy |
| 09/14/2010 | US7795235 Semi-soft c-class immunostimulatory oligonucleotides |
| 09/14/2010 | US7795232 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 09/14/2010 | US7795231 dissolving azithromycin in an aqueous solution comprising a strong acid, and adding solution to sterilized solution comprising a strong base, wherein strong acid has a pKa less than -1.74; pulmonary infection, nasopharyngeal infection, otic infection, ocular infection, dermal or vaginal infections |
| 09/14/2010 | US7795229 beta-lactam compounds having a C-glycoside in the molecule, in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor selected from atorvastatin and rosuvastatin; synergistic |
| 09/14/2010 | US7795227 Compounds and methods for treating seizure disorders |
| 09/14/2010 | US7795216 Methods for promoting composite tissue regeneration and uses thereof |
| 09/14/2010 | US7795212 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors |
| 09/14/2010 | US7795208 Using enzyme inhibitors of histone deacetylase to enhance progenitor cell differentiation; regenerative medicine and treatment of nervous system disorders |
| 09/14/2010 | US7795204 supplementing the diet of an athlete with substances which increase the concentration of nitric oxide (NO) or increase its half life in the body, in combination with a source of amino acids, may provide surprising enhancement of an athlete's muscle |
| 09/14/2010 | US7795203 topically applying an aqueous ophthalmic composition comprising N-acetylcarnosine, a N-acetylcarnosine derivative and a cellulose compound which increases intraocular absorption of N-acetylcarnosine; a hydrophilic hydrogel contact lens and an ocular polymer insert for topical application |
| 09/14/2010 | US7794987 (R)-2-acetamido-N-benzyl-3-methoxy-propionamide; O-methyl-N-acetyl-D-serine-m-fluorobenzylamide; epilepsy and other CNS disorders |
| 09/14/2010 | US7794957 Eukaryotic genes involved in adult lifespan regulation |
| 09/14/2010 | US7794944 Eubacterial tmRNA sequences and uses thereof |
| 09/14/2010 | US7794929 Detecting a colorectal cancer and/or gastric cancer, detecting selective hybridization of nucleic acid, therapeutic treatment of a cancer, a kit contains oligonucleotide |
| 09/14/2010 | US7794761 Administering benzoxazinoids-cyclic hydroxyamic acids, lactams, corresponding glucosides and 6-methoxy-2,3-benzoxazolinone, extracted from immature corn plants, in oral, parenteral, sustained release or transdermal dosage forms |
| 09/14/2010 | US7794757 Modulation of inflammation by hops fractions and derivatives |
| 09/14/2010 | US7794754 Methods for fine powder formation |
| 09/14/2010 | US7794753 Trans-tetracos-15-enoic acid and andrographolide; nontoxic, side effect free |
| 09/14/2010 | US7794752 Preparation and administration form comprising an acid-labile active compound |
| 09/14/2010 | US7794749 comprising L-Arginine, Xanthinol Nicotinate, and yohimbine; bioavailability; Croscarmellose and/or Crospovidone as agents of disintegration |
| 09/14/2010 | US7794748 Stable oral solid drug composition |
| 09/14/2010 | US7794747 Stabilization, homogenizing, sterile filtration, dehydration, reconstitution, ultrafiltration; storage stability; taxanes |
| 09/14/2010 | US7794745 Mixture of glucans and sterols |
| 09/14/2010 | US7794744 Nutritional modules |
| 09/14/2010 | US7794739 composition for applying to skin containing at least one purine nucleic acid-related substance chosen from adenosine monophosphate and salt thereof, at least one pyrimidine nucleic acid-related substance chosen from uridine monophosphate and salt thereof, and at least one additive; anti-aging, anti-acne |
| 09/14/2010 | US7794738 Compositions and methods for enhancing corticosteroid delivery |